Steph & Co’s Edwards Lifesciences EW Stock Holding History

Steph & Co’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-178	Closed	-$17K	–	268
2024 Q1	$17K	Hold	178	–	–	0.01%	233
2023 Q4	$13.6K	Hold	178	–	–	0.01%	208
2023 Q3	$12.3K	Sell	178 -90	-34%	-$7.23K	0.01%	235
2023 Q2	$25.3K	Hold	268	–	–	0.01%	183
2023 Q1	$22.2K	Hold	268	–	–	0.01%	182
2022 Q4	$20K	Buy	268 +46	+21%	+$3.54K	0.01%	192
2022 Q3	$18K	Hold	222	–	–	0.01%	181
2022 Q2	$21K	Buy	222 +20	+10%	+$2.07K	0.01%	177
2022 Q1	$24K	Sell	202 -40	-17%	-$4.49K	0.01%	229
2021 Q4	$31K	Hold	242	–	–	0.02%	238
2021 Q3	$27K	Hold	242	–	–	0.02%	210
2021 Q2	$25K	Sell	242 -12	-5%	-$1.13K	0.02%	187
2021 Q1	$21K	Buy	254 +12	+5%	+$1.01K	0.01%	190
2020 Q4	$22K	Hold	242	–	–	0.02%	191
2020 Q3	$19K	Hold	242	–	–	0.02%	182
2020 Q2	$17K	Sell	242 -25	-9%	-$1.78K	0.02%	189
2020 Q1	$17K	Hold	267	–	–	0.02%	185
2019 Q4	$21K	Buy	+267	New	+$20.8K	0.02%	192

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Steph & Co's EW Position: Q2 2024 in Review

Steph & Co sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 178 shares — an estimated $17K sold.

Steph & Co first reported a position in EW in Q4 2019 and held it in 18 quarters. The position peaked at $31K in Q4 2021. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

Steph & Co reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
Steph & Co sold 178 Edwards Lifesciences shares in Q2 2024, an estimated $17K.
Steph & Co first reported a position in Edwards Lifesciences in Q4 2019 and held it in 18 quarters.
Steph & Co's Edwards Lifesciences position peaked at $31K in Q4 2021.
1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Steph & Co's 13F filing for Q2 2024, filed 30 Jul 2024.